Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2020 Feb;37(2):347-357.
doi: 10.1007/s10815-019-01677-6. Epub 2020 Jan 4.

Live births after oocyte in vitro maturation with a prematuration step in women with polycystic ovary syndrome

Lan N Vuong  1   2   3 , Anh H Le  4   5 , Vu N A Ho  4   5 , Toan D Pham  4   5 , Flor Sanchez  6   7 , Sergio Romero  6   7 , Michel De Vos  6 , Tuong M Ho  4   5 , Robert B Gilchrist  8 , Johan Smitz  6
Affiliations

Live births after oocyte in vitro maturation with a prematuration step in women with polycystic ovary syndrome

Lan N Vuong et al. J Assist Reprod Genet. 2020 Feb.

Abstract

Purpose: Standard oocyte in vitro maturation (IVM) usually results in lower pregnancy rates than in vitro fertilization (IVF). IVM preceded by a prematuration step improves the acquisition of oocyte developmental competence and can enhance embryo quality (EQ). This study evaluated the effectiveness of a biphasic culture system incorporating prematuration and IVM steps (CAPA-IVM) versus standard IVM in women with polycystic ovarian morphology (PCOM).

Methods: Eighty women (age < 38 years, ≥ 25 follicles of 2-9 mm in both ovaries, no major uterine abnormalities) were randomized to undergo CAPA-IVM (n = 40) or standard IVM (n = 40). CAPA-IVM uses two steps: a 24-h prematuration step with C-type natriuretic peptide-supplemented medium, then 30 h of culture in IVM media supplemented with follicle-stimulating hormone and amphiregulin. Standard IVM was performed using routine protocols.

Results: A significantly higher proportion of oocytes reached metaphase II at 30 h after CAPA-IVM versus standard IVM (63.6 vs 49.0; p < 0.001) and the number of good quality embryos per cumulus-oocyte complex tended to be higher (18.9 vs 12.7; p = 0.11). Clinical pregnancy rate per embryo transfer was 63.2% in the CAPA-IVM versus 38.5% in the standard IVM group (p = 0.04). Live birth rate per embryo transfer was not statistically different between the CAPA-IVM and standard IVM groups (50.0 vs 33.3% [p = 0.17]). No malformations were reported and birth weight was similar in the two treatment groups.

Conclusions: Use of the CAPA-IVM system significantly improved maturation and clinical pregnancy rates versus standard IVM in patients with PCOM. Furthermore, live births after CAPA-IVM are reported for the first time.

Keywords: C-type natriuretic peptide; In vitro fertilization; In vitro maturation; Oocyte prematuration; Polycystic ovary syndrome.

PubMed Disclaimer

Conflict of interest statement

All authors have no conflicts of interest to declare.

Figures

Fig. 1
Fig. 1
CONSORT diagram. AFC, antral follicle count; CAPA-IVM, capacitation in vitro maturation; FET, frozen embryo transfer; IUI, intrauterine insemination; IVF, in vitro fertilization; IVM, in vitro maturation; OPU, oocyte pick-up; PGS, preimplantation genetic screening
Fig. 2
Fig. 2
Study schedule for CAPA-IVM and standard IVM (control). Patients were randomized to CAPA-IVM or standard IVM. The stimulation protocols are identical in the two arms. Patients received approximately 2.5 days of gonadotropin priming and no human chorionic gonadotropin (hCG) priming. CAPA-IVM group allocated patients had their oocytes 24-h longer in a prematuration culture (orange bar). All embryos were vitrified and transferred in subsequent cycles. CAPA, capacitation prematuration; D3, day 3; Gn, gonadotrophin; IVM, in vitro maturation; OCP, oral contraceptive pill; VIT, vitrification
Fig. 3
Fig. 3
Hormonal profiles during CAPA-IVM (n = 40) compared with standard IVM (n = 40). Serum concentrations of follicle-stimulating hormone (FSH), luteinizing hormone (LH), estradiol, and progesterone were measured from the day of first visit until the day of immature cumulus-oocyte complex retrieval for both IVM treatments. Values are mean ± standard deviation
Fig. 4
Fig. 4
Comparison of maturation rate between standard and CAPA-IVM in follicles of < 6 mm and ≥ 6 mm. Values are mean ± standard deviation; with Tukey’s HSD-adjusted p value
See this image and copyright information in PMC

Similar articles

See all similar articles

Cited by

See all "Cited by" articles

References

    1. Edwards RG. Maturation in vitro of mouse, sheep, cow, pig, rhesus monkey and human ovarian oocytes. Nature. 1965;208:349–351. doi: 10.1038/208349a0. - DOI - PubMed
    1. Paulson RJ, Fauser B, Vuong LTN, Doody K. Can we modify assisted reproductive technology practice to broaden reproductive care access? Fertil Steril. 2016;105:1138–1143. doi: 10.1016/j.fertnstert.2016.03.013. - DOI - PubMed
    1. Practice Committees of the American Society for Reproductive M, the Society for Assisted Reproductive T In vitro maturation: a committee opinion. Fertil Steril. 2013;99:663–666. doi: 10.1016/j.fertnstert.2012.12.031. - DOI - PubMed
    1. Julania S, Walls ML, Hart R. The place of in vitro maturation in PCO/PCOS. Int J Endocrinol. 2018;2018:5750298. doi: 10.1155/2018/5750298. - DOI - PMC - PubMed
    1. Child TJ, Abdul-Jalil AK, Gulekli B, Tan SL. In vitro maturation and fertilization of oocytes from unstimulated normal ovaries, polycystic ovaries, and women with polycystic ovary syndrome. Fertil Steril. 2001;76:936–942. doi: 10.1016/S0015-0282(01)02853-9. - DOI - PubMed

Substances